Compugen Ltd. (CGEN)
NASDAQ: CGEN · Real-Time Price · USD
1.410
-0.050 (-3.42%)
Apr 1, 2025, 4:00 PM EDT - Market closed
Compugen Revenue
In the year 2024, Compugen had annual revenue of $27.86M, down -16.72%. Compugen had revenue of $1.47M in the quarter ending December 31, 2024, a decrease of -95.60%.
Revenue (ttm)
$27.86M
Revenue Growth
-16.72%
P/S Ratio
4.69
Revenue / Employee
$376,541
Employees
74
Market Cap
131.85M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 27.86M | -5.60M | -16.72% |
Dec 31, 2023 | 33.46M | 25.96M | 346.12% |
Dec 31, 2022 | 7.50M | 1.50M | 25.00% |
Dec 31, 2021 | 6.00M | 4.00M | 200.00% |
Dec 31, 2020 | 2.00M | - | - |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
CGEN News
- 6 days ago - Compugen to Participate in Multiple Virtual Investor Conferences in April 2025 - PRNewsWire
- 4 weeks ago - Compugen Ltd. (CGEN) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Compugen Reports Fourth Quarter and Full Year 2024 Results - PRNewsWire
- 4 weeks ago - Compugen to Participate in a Fireside Chat at the 2025 Leerink Partners Global Healthcare Conference - PRNewsWire
- 4 weeks ago - Compugen Enhances its AI/ML Predictive Computational Discovery Platform, Unigen™ with Ultima Genomics' Single Cell Genomics Sequencing Technology - PRNewsWire
- 6 weeks ago - Compugen to Release Fourth Quarter and Full Year 2024 Financial Results on Tuesday, March 4, 2025 - PRNewsWire
- 6 weeks ago - Compugen: Immuno-Oncology Innovator Poised For A Comeback - Seeking Alpha
- 2 months ago - Compugen to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - PRNewsWire